James A. Harper

Early Oncology R&D
Cambridge, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Redefining morbidity and mortality meetings in ophthalmology: a wider remit for improved learning.

Redefining morbidity and mortality meetings in ophthalmology: a wider remit for improved learning.

Journal: Eye (London, England)
Published: February 11, 2026

The Immunopathogenesis of uveitis.

The Immunopathogenesis of uveitis.

Journal: Frontiers in medicine
Published: October 01, 2025

Recruitment, consent and retention of participants in randomised controlled trials: a review of trials published in the National Institute for Health Research (NIHR) Journals Library (1997-2020).

Recruitment, consent and retention of participants in randomised controlled trials: a review of trials published in the National Institute for Health Research (NIHR) Journals Library (1997-2020).

Journal: BMJ open
Published: February 15, 2022

Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade.

Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade.

Journal: Journal for immunotherapy of cancer
Published: February 06, 2022

Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade.

Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade.

Journal: Cancer research
Published: December 02, 2021

Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity.

Recombinant Newcastle Disease Virus Immunotherapy Drives Oncolytic Effects and Durable Systemic Antitumor Immunity.

Journal: Molecular cancer therapeutics
Published: October 20, 2020

Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro.

Oncolytic Newcastle disease virus activation of the innate immune response and priming of antitumor adaptive responses in vitro.

Journal: Cancer immunology, immunotherapy : CII
Published: September 23, 2019

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.

Rational Selection of Syngeneic Preclinical Tumor Models for Immunotherapeutic Drug Discovery.

Journal: Cancer immunology research
Published: May 20, 2016

Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model.

Transformation of the tumour microenvironment by a CD40 agonist antibody correlates with improved responses to PD-L1 blockade in a mouse orthotopic pancreatic tumour model.

Journal: Oncotarget
Published: December 18, 2015

Epithelial-mesenchymal transition and nuclear β-catenin induced by conditional intestinal disruption of Cdh1 with Apc is E-cadherin EC1 domain dependent.

Epithelial-mesenchymal transition and nuclear β-catenin induced by conditional intestinal disruption of Cdh1 with Apc is E-cadherin EC1 domain dependent.

Journal: Oncotarget
Published: October 07, 2015

Regulation of the anti-tumour immune response by cancer-associated fibroblasts.

Regulation of the anti-tumour immune response by cancer-associated fibroblasts.

Journal: Seminars in cancer biology
Published: August 08, 2013

Lactic acidosis secondary to metformin overdose: a case report.

Lactic acidosis secondary to metformin overdose: a case report.

Journal: Journal of medical case reports
Published: February 16, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026